Download PDF
AJP Rep 2012; 02(01): 001-006
DOI: 10.1055/s-0031-1296027
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Antenatal and Postnatal Diagnosis of Coxsackie B4 Infection: Case Series

Jennifer C. Hunt
1   Department of Obstetrics and Gynaecology
,
Carol Schneider
1   Department of Obstetrics and Gynaecology
,
Savas Menticoglou
1   Department of Obstetrics and Gynaecology
,
Jayantha Herath
2   Department of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada
,
Marc R. Del Bigio
2   Department of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada
› Author Affiliations
Further Information

Publication History

28 July 2011

27 August 2011

Publication Date:
25 November 2011 (online)

   Permissions and Reprints

Abstract

Enteroviruses are a common cause of neonatal infection. In particular, Coxsackie B viruses are often associated with severe, fatal disease. The antenatal diagnosis of Coxsackie B viral infections is uncommon. We present a unique case of Coxsackie B4 virus ventriculitis and myocarditis causing fetal hydrops at 22 weeks gestation. Transmission was inferred by viral isolation from the amniotic fluid and by placental pathology. We also describe two additional cases of fatal neonatal Coxsackie B4 infection complicated by myocarditis and encephalitis with cerebral necrosis in a 4-day-old female and by myocarditis, spinal leptomeningitis, and hepatitis in a 4-day-old male. Transplacental acquisition of infection carries a poor prognosis. We propose that Coxsackie B virus should be considered in the investigation of nonimmune hydrops, particularly in the presence of cardiac dysfunction.

Keywords

coxsackie B virus - hydrops - myocarditis - cerebritis - ventriculitis
 

  • References

  • 1 Moore M, Kaplan MH, McPhee J, Bregman DJ, Klein SW. Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep 1984; 99 (5) 515-522
    PubMedGoogle Scholar
  • 2 Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983; 5 (6) 1019-1032
    CrossrefPubMedGoogle Scholar
  • 3 Romero JR. Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol 2008; 323 (3) 223-239
    PubMedGoogle Scholar
  • 4 Sawyer MH. Enterovirus infections: diagnosis and treatment. Curr Opin Pediatr 2001; 13 (1) 65-69
    CrossrefPubMedGoogle Scholar
  • 5 Theodoridou M, Kakourou T, Laina I, Mostrou G, Tsakris A. Vesiculopapular rash as a single presentation in intrauterine coxsackie virus infection. Eur J Pediatr 2002; 161 (7) 412-413
    CrossrefPubMedGoogle Scholar
  • 6 Bryant PA, Tingay D, Dargaville PA, Starr M, Curtis N. Neonatal coxsackie B virus infection-a treatable disease?. Eur J Pediatr 2004; 163 (4-5) 223-228
    CrossrefPubMedGoogle Scholar
  • 7 Callen J, Paes BA. A case report of a premature infant with coxsackie B1 meningitis. Adv Neonatal Care 2007; 7 (5) 238-247
    CrossrefPubMedGoogle Scholar
  • 8 Cheng LL, Ng PC, Chan PK, Wong HL, Cheng FW, Tang JW. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 2006; 118 (3) e929-e933
    CrossrefPubMedGoogle Scholar
  • 9 Konstantinidou A, Anninos H, Spanakis N , et al. Transplacental infection of Coxsackievirus B3 pathological findings in the fetus. J Med Virol 2007; 79 (6) 754-757
    CrossrefPubMedGoogle Scholar
  • 10 Freund MW, Kleinveld G, Krediet TG, van Loon AM, Verboon-Maciolek MA. Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed 2010; 95 (3) F206-F212
    CrossrefPubMedGoogle Scholar
  • 11 Bauer S, Gottesman G, Sirota L, Litmanovitz I, Ashkenazi S, Levi I. Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. Eur J Pediatr 2002; 161 (9) 491-493
    CrossrefPubMedGoogle Scholar
  • 12 Ouellet A, Sherlock R, Toye B, Fung KF. Antenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth. Infect Dis Obstet Gynecol 2004; 12 (1) 23-26
    CrossrefPubMedGoogle Scholar
  • 13 Erickson LS, Hoyle G, Abramson J, Hester LC, Shetty AK. Coxsackie B1 infection associated with ventriculitis. Pediatr Infect Dis J 2003; 22 (8) 750-751
    PubMedGoogle Scholar
  • 14 Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholm H. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995; 38 (11) 1371-1373
    CrossrefPubMedGoogle Scholar
  • 15 Tracy S, Gauntt C. Group B coxsackievirus virulence. Curr Top Microbiol Immunol 2008; 323: 49-63
    PubMedGoogle Scholar
  • 16 Euscher E, Davis J, Holzman I, Nuovo GJ. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol 2001; 98 (6) 1019-1026
    CrossrefPubMedGoogle Scholar
  • 17 Watson WJ, Awadallah S, Jaqua MJ. Intrauterine infection with coxsackievirus: is it a cause of congenital cardiac malformations?. Infect Dis Obstet Gynecol 1995; 3 (2) 79-81
    CrossrefPubMedGoogle Scholar
  • 18 Gauntt CJ, Gudvangen RJ, Brans YW, Marlin AE. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system. Pediatrics 1985; 76 (1) 64-68
    PubMedGoogle Scholar
  • 19 Kamei S, Hersch SM, Kurata T, Takei Y. Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue. Acta Neuropathol 1990; 80 (2) 216-221
    CrossrefPubMedGoogle Scholar
  • 20 Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003; 163 (4) 1379-1393
    CrossrefPubMedGoogle Scholar
  • 21 Feuer R, Whitton JL. Preferential coxsackievirus replication in proliferating/activated cells: implications for virus tropism, persistence, and pathogenesis. Curr Top Microbiol Immunol 2008; 323: 149-173
    PubMedGoogle Scholar
  • 22 Freimuth P, Philipson L, Carson SD. The coxsackievirus and adenovirus receptor. Curr Top Microbiol Immunol 2008; 323: 67-87
    PubMedGoogle Scholar
  • 23 Honda T, Saitoh H, Masuko M , et al. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 2000; 77 (1) 19-28
    CrossrefPubMedGoogle Scholar
  • 24 Benirschke K, Kibrick S. Acute aseptic myocarditis and meningoencephalitis in the newborn child infected with coxsackle virus group B, type 3. N Engl J Med 1956; 255 (19) 883-889
    CrossrefPubMedGoogle Scholar
  • 25 Estes ML, Rorke LB. Liquefactive necrosis in Coxsackie B encephalitis. Arch Pathol Lab Med 1986; 110 (11) 1090-1092
    PubMedGoogle Scholar
  • 26 Cree BC, Bernardini GL, Hays AP, Lowe G. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 2003; 60 (1) 107-112
    CrossrefPubMedGoogle Scholar
  • 27 Strong BS, Young SA. Intrauterine coxsackie virus, group B type 1, infection: viral cultivation from amniotic fluid in the third trimester. Am J Perinatol 1995; 12 (2) 78-79
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Batcup G, Holt P, Hambling MH, Gerlis LM, Glass MR. Placental and fetal pathology in Coxsackie virus A9 infection: a case report. Histopathology 1985; 9 (11) 1227-1235
    CrossrefPubMedGoogle Scholar